ArteraAI

Harnessing AI to accelerate personalized cancer treatment ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive…

The funding will support the international expansion and commercial growth of the company and its first-of-its-kind test ArteraAI, the developer…

The collaboration aims to further validate the ArteraAI Prostate Test in the Hispanic population ArteraAI, the developer of multimodal artificial…

ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tools, announced a strategic collaborative…

Data published in the NEJM Evidence shows promise for personalized use of short-term ADT in men with predominantly intermediate-risk prostate…

With the shared mission to improve the lives of those touched by cancer, both parties collaborate in the fight against the disease ArteraAI, the…